Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997025981 - MEDICAL USE

Publication Number WO/1997/025981
Publication Date 24.07.1997
International Application No. PCT/EP1997/000197
International Filing Date 14.01.1997
Chapter 2 Demand Filed 23.07.1997
IPC
A61K 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61P 37/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
A61P 37/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
08Antiallergic agents
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • SMITHKLINE BEECHAM PLC [GB]/[GB] (AllExceptUS)
  • CHRISTIE, Gary [GB]/[GB] (UsOnly)
  • WESTON, Beverley, Jane [GB]/[GB] (UsOnly)
Inventors
  • CHRISTIE, Gary
  • WESTON, Beverley, Jane
Agents
  • WEST, Vivien
  • GIDDINGS, Peter, John
Priority Data
9601042.617.01.1996GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MEDICAL USE
(FR) UTILISATION MEDICALE
Abstract
(EN)
Certain inhibitors of matrix metalloproteases such as collagenase are capable of inhibiting the release of human soluble CD23 and are therefore useful in the treatment and prophylaxis of conditions in which an excess of s-CD23 is implicated, such as allergy and autoimmune disease.
(FR)
Certains inhibiteurs de métalloprotéases matricielles telles que la collagénase peuvent inhiber la libération de la protéine CD23 humaine soluble et sont, par conséquent, utiles dans le traitement et la prophylaxie d'états dans lesquels un excès de CD23 soluble est impliqué, tels que l'allergie et les maladies auto-immunes.
Also published as
Latest bibliographic data on file with the International Bureau